232
Participants
Start Date
December 9, 2024
Primary Completion Date
October 30, 2025
Study Completion Date
December 4, 2025
PF-07976016
Taken once daily
Placebo
Taken once daily
Rochester Clinical Research, LLC, Rochester
Capital Area Research, LLC, Camp Hill
Selma Medical Associates, Winchester
Accellacare - Wilmington, Wilmington
Rophe Adult and Pediatric Medicine/SKYCRNG, Union City
St Johns Center for Clinical Research, Saint Augustine
Westside Center for Clinical Research, Jacksonville
New Horizon Research Center, Miami
Renstar Medical Research, Ocala
L-MARC Research Center, Louisville
StudyMetrix Research, City of Saint Peters
Cotton O'Neil Diabetes & Endocrinology, Topeka
Pennington Biomedical Research Center, Baton Rouge
AMR Clinical, Norman
Cornerstone Nutrition and Diabetes, Norman
Velocity Clinical Research, Dallas, Dallas
UT Southwestern Medical Center, Dallas
Consano Clinical Research, LLC, Shavano Park
Elligo Clinical Research Center, Austin
Texas Diabetes & Endocrinology, P.A., Austin
Clinical & Translational Research Center, Aurora
University of Colorado Anschutz Medical Campus, Aurora
Chrysalis Clinical Research, St. George
Southwest Internal Medicine, PC, St. George
Artemis Institute for Clinical Research, San Diego
Anaheim Clinical Trials, LLC, Anaheim
East-West Medical Research Institute, Honolulu
Ocean West Research Clinic, Surrey
Dawson Clinical Research Inc., Guelph
The Wharton Medical Clinic Clinical Trials Inc., Hamilton
Milestone Research Inc., London
Canadian Phase Onward, Toronto
Centrum Zdrowia Metabolicznego Pawel Bogdanski, Poznan
Medicome Sp. z o. o., Oświęcim
Ekamed, Lublin
Centrum Badan Klinicznych PI-House sp. z o.o., Gdansk
Centrum Medyczne Pratia Gdynia, Gdynia
Lead Sponsor
Pfizer
INDUSTRY